{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T15:44:07Z","timestamp":1771688647986,"version":"3.50.1"},"reference-count":15,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:p>We report on 2 patients who developed widespread cerebral vasospasm and arterial ischemic strokes (AIS) after application of intrathecal (IT) cytarabine. In a 3-year-old child with acute lymphoblastic leukemia (ALL), left leg weakness, hyperreflexia, and clonus were noted 4 days after her first dose of IT cytarabine during the induction phase of her chemotherapy. Cerebral MRI revealed multiple acute cerebral ischemic infarcts and widespread cerebral vasospasm. A 5-year-old girl complained of right arm and leg pain and began limping 11 days after IT cytarabine. Symptoms progressed to right dense hemiplegia, left gaze deviation, headache, and speech arrest. MRI revealed 2 large cortical areas of diffusion restriction in the right frontal and left parietal lobes. Cerebral magnetic resonance angiography (MRA) showed irregular narrowing affecting much of the intracranial arterial circulation. Although the first child fully recovered from her neurologic symptoms, the second patient had persistent hemiplegia on follow-up. Including this report, there are now 4 pediatric ALL cases of severe cerebral vasospasm and AIS in the context of IT cytarabine administration, strongly suggesting a true association. Differential diagnosis and management issues are discussed. Along with the more widespread use of MRI and MRA, the true frequency of this severe adverse effect will become clearer in future. For any child with neurologic symptoms within hours or days of receiving IT cytarabine, a low threshold for cerebral imaging with MRI and MRA is recommended.<\/jats:p>","DOI":"10.1542\/peds.2015-2143","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T02:20:16Z","timestamp":1453256416000},"source":"Crossref","is-referenced-by-count":22,"title":["Severe Cerebral Vasospasm and Childhood Arterial Ischemic Stroke After Intrathecal Cytarabine"],"prefix":"10.1542","volume":"137","author":[{"given":"Daniel","family":"Tibussek","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada;"},{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children\u2019s Hospital, Heinrich-Heine University, D\u00fcsseldorf, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rungrote","family":"Natesirinilkul","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Neurology, The Johns Hopkins Hospital, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo R.","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"deVeber","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"issue":"2","key":"2021120907165357100_B1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.critrevonc.2012.04.003","article-title":"Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia\/lymphoma.","volume":"84","author":"Vagace","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"2021120907165357100_B2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jmri.22592","article-title":"Intracranial arterial wall imaging using three-dimensional high isotropic resolution black blood MRI at 3.0 Tesla.","volume":"34","author":"Qiao","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"2021120907165357100_B3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3174\/ajnr.A3909","article-title":"High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis.","volume":"35","author":"Obusez","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"2021120907165357100_B4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPH.0b013e3180335043","article-title":"Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.","volume":"29","author":"Pound","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"2021120907165357100_B5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/ped.12394","article-title":"Diffuse cerebral vasospasm with infarct after intrathecal cytarabine in childhood leukemia.","volume":"56","author":"Yoon","year":"2014","journal-title":"Pediatr Int"},{"issue":"2","key":"2021120907165357100_B6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.WNL.0000042095.49520.1E","article-title":"Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm.","volume":"60","author":"Henderson","year":"2003","journal-title":"Neurology"},{"issue":"4\u20135","key":"2021120907165357100_B7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.thromres.2003.10.007","article-title":"Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy.","volume":"111","author":"Athale","year":"2003","journal-title":"Thromb Res"},{"issue":"3","key":"2021120907165357100_B8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/leu.2012.290","article-title":"The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.","volume":"27","author":"Truelove","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"2021120907165357100_B9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1200\/JCO.1991.9.4.679","article-title":"Cytarabine and neurologic toxicity.","volume":"9","author":"Baker","year":"1991","journal-title":"J Clin Oncol"},{"issue":"9","key":"2021120907165357100_B10","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1200\/JCO.1999.17.9.2804","article-title":"Contribution of single-photon emission computed tomography in the diagnosis and follow-up of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia.","volume":"17","author":"V\u00e9ra","year":"1999","journal-title":"J Clin Oncol"},{"issue":"10","key":"2021120907165357100_B11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1474-4422(12)70135-7","article-title":"Reversible cerebral vasoconstriction syndrome.","volume":"11","author":"Ducros","year":"2012","journal-title":"Lancet Neurol"},{"issue":"9","key":"2021120907165357100_B12","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","article-title":"Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.","volume":"39","author":"Roach","year":"2008","journal-title":"Stroke"},{"key":"2021120907165357100_B13","article-title":"Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition).","volume-title":"Chest.","author":"Monagle","year":"2008"},{"issue":"17","key":"2021120907165357100_B14","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.","volume":"31","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021120907165357100_B15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood-2011-06-361535","article-title":"Safety of anticoagulants in children with arterial ischemic stroke.","volume":"119","author":"Schechter","year":"2012","journal-title":"Blood"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-2143\/1094776\/peds_20152143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-2143\/1094776\/peds_20152143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:50:09Z","timestamp":1639101009000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/137\/2\/e20152143\/52751\/Severe-Cerebral-Vasospasm-and-Childhood-Arterial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,1]]},"published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-2143","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]},"article-number":"e20152143"}}